The Xenopus oocyte: A model for studying the metabolic regulation of cancer cell death

Seminars in Cell and Developmental Biology

Volumn 23, Issue 4, 2012, Pages 412-418

  Nutt, Leta K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Apoptosis; Cancer; Caspase 2; Metabolism; Model system; Xenopus laevis

Indexed keywords

FATTY ACID SYNTHASE; GLUTAMINE; LACTIC ACID; PENTOSE PHOSPHATE;

APOPTOSIS; BIOCHEMISTRY; CANCER CELL; CELL DEATH; EGG; METABOLIC REGULATION; MOLECULAR MECHANICS; NONHUMAN; OOCYTE; REVIEW; XENOPUS LAEVIS;

XENOPUS LAEVIS;

EID: 84861995187     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.03.015     Document Type: Review

References (71)

1. Warburg O. On the origin of cancer cells. Science 1956, 123(February):309.
2. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nature reviews. Cancer 2011, 11(February):85.
3. Menendez J.A., Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature reviews. Cancer 2007, 7(October):763.
4. Pani G., Giannoni E., Galeotti T., Chiarugi P. Redox-based escape mechanism from death: the cancer lesson. Antioxidants and Redox Signaling 2009, 11(November):2791.
5. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(March):646.
6. Gurdon J.B. The control of gene expression in animal development 1974, Harvard University Press, Cambridge, MA.
7. Dworkin M.B., Dworkin-Rastl E. Metabolic regulation during early frog development: glycogenic flux in Xenopus oocytes, eggs, and embryos. Developmental Biology 1989, 132(April):512.
8. Deming P., Kornbluth S. Study of apoptosis in vitro using the Xenopus egg extract reconstitution system. Methods in Molecular Biology 2006, 322:379.
9. Hirschhaeuser F., Sattler U.G., Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Research 2011, 71(November):6921.
10. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., Saavedra E. Energy metabolism in tumor cells. The FEBS Journal 2007, 274(March):1393.
11. Reitzer L.J., Wice B.M., Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. The Journal of Biological Chemistry 1979, 254(April):2669.
12. Bonnet S., Archer S.L., Allalunis-Turner J., Haromy A., Beaulieu C., Thlmpson R., et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007, 11(January):37.
13. Majewski N., Nogueira V., Bhaskar P., Coy P.E., Sheen J.E., Gottlob K., et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Molecular Cell 2004, 16(December):819.
14. Zhao Y., Altman B.J., Coloff J.L., Herman C.E., Jacobs S.R., Wieman H.L., et al. Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Molecular and Cellular Biology 2007, 27(June):4328.
15. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91(October):231.
16. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278(October):687.
17. Maurer U., Charvet C., Wagman A.S., Dejardin E., Green D.R. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Molecular Cell 2006, 21(March):749.
18. Pelicano H., Martin D.S., Xu R.H., Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25(August):4633.
19. Preller A., Kessi E., Ureta T. Glycogen synthesis by the direct or indirect pathways depends on glucose availability: in vivo studies in frog oocytes. FEBS Letters 2007, 581(February):663.
20. Wilson C.A., Preller A., Valenzuela M.A., Ureta T. Measurement of glycogen synthase activity in crude extracts by CE. Electrophoresis 2007, 28(August):2888.
21. Baez M., Preller A., Ureta T. Frog oocyte glycogen synthase: enzyme regulation under in vitro and in vivo conditions. Archives of Biochemistry and Biophysics 2003, 413(May):9.
22. Ureta T., Radojkovic J. Microinjected frog oocytes: a first-rate test tube for studies on metabolism and its control. BioEssays 1985, 2(5):221-226.
23. Ureta T., Preller A., Kessi E. Frog oocytes: a living test tube for studies on metabolic regulation. IUBMB Life 2001, 51(January):5.
24. Preller A., Guixe V., Ureta T. In vivo operation of the pentose phosphate pathway in frog oocytes is limited by NADP+ availability. FEBS Letters 1999, 446(March):149.
25. Cicirelli M.F., Smith L.D. Energy metabolism and pyridine nucleotide levels during Xenopus oocyte maturation. Development Growth and Differentiation 1985, 27:283.
26. Thoman M., Gerhart J.C. Absence of dorsal-ventral differences in energy metabolism in early embryos of Xenopus laevis. Developmental Biology 1979, 68(January):191.
27. Dworkin M.B., Dworkin-Rastl E. Regulation of carbon flux from amino acids into sugar phosphates in Xenopus embryos. Developmental Biology 1990, 138(March):177.
28. Dworkin M.B., Dworkin-Rastl E. Metabolic regulation during early frog development. Identification of proteins labeled by 32P-glycolytic intermediates. The Journal of Biological Chemistry 1987, 262(December):17038.
29. Eppig J.J., Dumont J.N. Defined nutrient medium for the in vitro matintenance of Xenopus laevis oocytes. In Vitro 1976, 12:418.
30. Nutt L.K., Margolis S.S., Jensen M., Herman C.E., Dunphy W.E., et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 2005, 123(October):89.
31. Vastag L., Jorgensen P., Peshkin L., Wei R., Rabinowitz J.D., Kirschner M.W. Remodeling of the metabolome during early frog development. PLoS One 2011, 6:e16881.
32. Mazurek S., Boschek C.B., Hugo F., Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Seminars in Cancer Biology 2005, 15(August):300.
33. Ashizawa K., Willingham M.C., Liang C.M., Cheng S.Y. In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate. The Journal of Biological Chemistry 1991, 266:16842.
34. Marchut E., Guminska M., Kedryna T. The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells. Acta Biochimica Polonica 1986, 33:7.
35. Presek P., Reinacher M., Eigenbrodt E. Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus. FEBS Letters 1988, 242(December):194.
36. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452(March):230.
37. Christofk H.R., Vander Heiden M.G., Wu N., Asara J.M., Cantley L.C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008, 452(March):181.
38. Dang C.V. PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect. Science Signaling 2009, 2:pe75.
39. Vander heiden M.G., Locasale J.W., Swanson K.D., Sharfi H., Heffron G.J., Amador-Noguez D., et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 329(September):1492.
40. Klein S.L., Strausberg R.L., Wagner L., Pontius J., Slifton S.W., Richarson P. Genetic and genomic tools for Xenopus research: the NIH Xenopus initiative. Developmental Dynamics: An Official Publication of the American Association of Anatomists 2002, 225(December):384.
41. Lowry O.H., Passonneau J.V., Hasselberger F.X., Schulz D.W. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. The Journal of Biological Chemistry 1964, 239(January):18.
42. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(December):18782.
43. Kovacevic Z. The pathway of glutamine and glutamate oxidation in isolated mitochondria from mammalian cells. The Biochemical Journal 1971, 125(December):757.
44. Matsuno T. Pathway of glutamate oxidation and its regulation in the HuH13 line of human hepatoma cells. Journal of Cellular Physiology 1991, 148(August):290.
45. Wise D.R., Thompson C.B. Glutamine addiction: a new therapeutic target in cancer. Trends in Biochemical Sciences 2010, 35(August):427.
46. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M, Wehrli S., Thompson C.B. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(December):19345.
47. Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. The Journal of Cell Biology 2007, 178(July):93.
48. Salomon De Legname H. Biochemical studies on the energetics of Bufo arenarum segmenting eggs. Acta Embryologiae Experimentalis 1969, 3:187.
49. Shiokawa K., Tashiro K., Atsuchi Y., Kawazoe Y. Alteration of the pool of free amino acids during oogenesis, oocyte maturation and embryogenesis of Xenopus laevis and Xenopus borealis. Zoological Science 1986, 3:793.
50. Brinster R.L. Handbook of physiology 1975, vol. 2. p. 165-85.
51. Bae I.H., Foote R.H. Utilization of glutamine for energy and protein synthesis by cultured rabbit follicular oocytes. Experimental Cell Research 1975, 90(February):432.
52. Bae I.H., Foote R.H. Carbohydrate and amino acid requirements and ammonia production of rabbit follicular oocytes matured in vitro. Experimental cell research 1975, 91(March):113.
53. Stryer L. Biochemistry 1988, W.H. Freeman and Company, New York.
54. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126(July):107.
55. Jiang P., Du W., Wang X., Mancuso A., Gao X., Wu M., Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology 2011, 13(March):310.
56. Vaughn A.E., Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nature Cell Biology 2008, 10(December):1477.
57. Schafer Z.T., Grassian A.R., Song L., Jiang Z., Gerhart-Hines Z., Irie H.Y., et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461(September):109.
58. Chandra D., Bratton S.B., Person M.D., Tian Y., Martin A.G., Ayres M., et al. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome. Cell 2006, 125(June):1333.
59. Nutt L.K., Buchakjian M.R., Gan E., Darbandi R., Yoon S.Y., Wu J.Q., et al. Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2. Developmental Cell 2009, 16(June):856.
60. Kuhajda F.P., Jenner K., Wood F.D., Hennigar R.A., Jacobs L.B., Dick J.D., Pasternack G.R. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(July):6379.
61. Nomura D.K., Long J.Z., Niessen S., Hoover H.S., Ng S.W., Cravatt B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 2010, 140(January):49.
62. Kuhajda F.P. Fatty acid synthase and cancer: new application of an old pathway. Cancer Research 2006, 66(June):5977.
63. Knowles L.M., Yang C., Osterman A., Smith J.W. Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4. The Journal of Biological Chemistry 2008, 283(November):31378.
64. Zhou W., Simpson P.J., McFadden J.M., Townsend C.A., Medghalchi S.M., Vadlamudi A., et al. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Research 2003, 63(November):7330.
65. Pizer E.S., Thupari J., Han W.F., Pinn M.L., Chrest F.J., Frehywot G.L., et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Research 2000, 60(January):213.
66. Jorgensen P., Steen J.A., Steen H., Kirschner M.W. The mechanism and pattern of yolk consumption provide insight into embryonic nutrition in Xenopus. Development 2009, 136(May):1539.
67. Dworkin M.B., Dworkin-Rastl E. Metabolic regulation during early frog development: flow of glycolytic carbon into phospholipids in Xenopus oocytes and fertilized eggs. Developmental Biology 1989, 132(April):524.
68. Zu X.L., Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochemical and Biophysical Research Communications 2004, 313(January):459.
69. Mazurek S., Michel A., Eigenbrodt E. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. The Journal of Biological Chemistry 1997, 272(February):4941.
70. Mazurek S., Grimm H., Wilker S., Leib S., Eigenbrodt E. Metabolic characteristics of different malignant cancer cell lines. Anticancer Research 1998, 18(September-October):3275.
71. Weinhouse S. On respiratory impairment in cancer cells. Science 1956, 124(August):267.